Buy & Sell Abbott Laboratories (ABT) – Abbott Laboratories Price Today
DBV Technologies plans BLA submission for VIASKIN® Peanut patch in kids 4-7 after FDA collaboration.
DBV Technologies is preparing to submit a Biologics License Application (BLA) for its VIASKIN® Peanut patch aimed at children aged 4 to 7 years. The company has engaged in detailed discussions with the FDA to ensure a thorough and efficient review pr...
Fidelity Advisor Series VIII increases voting rights in Renk Group AG to 3.23%.
Fidelity Advisor Series VIII, based in Boston, has raised its voting rights stake in Renk Group AG to 3.23% as of June 24, 2026. This includes 3.04% direct voting rights and 0.19% through stock loan instruments. The total voting rights are based on 1...
Fidelity Advisor Series VIII increases stake in Renk Group AG to 3.23%
Fidelity Advisor Series VIII has increased its voting rights in Renk Group AG to 3.23% as of June 24, 2026. This includes 3.04% voting rights attached to shares and 0.19% through stock loan instruments. The total voting rights represent a significant...
No buybacks of cooperative investment certificates reported by CRCAM Toulouse for week of June 22-26, 2026
CRCAM Toulouse announced that no repurchases of its cooperative investment certificates (CCI) were made during the week of June 22 to June 26, 2026. This update is part of their regular weekly disclosure on CCI transactions, reflecting no activity in...
Hyperliquid Strategies stock joins Russell 3000, Russell 2000, and S&P Global BMI indexes.
Hyperliquid Strategies Inc (HSI) announced that its common stock has been added to the Russell 3000 and Russell 2000 indexes as of June 29, 2026, and to the S&P Global Broad Market Index since June 22, 2026. These inclusions reflect the company's gro...
UMH Properties added to Russell 2000 Value-Defensive Index for stability and quality recognition
UMH Properties, a REIT specializing in manufactured home communities, was added to the Russell 2000 Value-Defensive Index after the June 26, 2026 market close. This index highlights smaller-cap stocks with high quality and low volatility, reflecting ...
Silo Pharma advances PTSD treatment with nasal spray device study ahead of FDA meeting
Silo Pharma is conducting a robustness study on its microchip-based nasal spray delivery system for SPC-15, a PTSD treatment, to evaluate device performance and formulation stability. This study supports their plan to request a Type C meeting with th...
SpaceX shares rebound with bullish options bets amid mobile carrier buyout rumors
SpaceX shares have recovered after a 35% drop from their post-IPO peak, driven by strong bullish activity in options trading. Traders are buying significantly more call options than puts, signaling confidence in the stock's upside. The rally follows ...
Digital Realty announces $2.35B secondary stock offering by Blackstone after data center acquisition closes.
Digital Realty Trust announced a $2.35 billion underwritten public offering of common stock by Blackstone affiliates, contingent on the closing of Digital Realty's acquisition of Blackstone's interests in two joint ventures. The shares offered are no...
FDA clears Gain Therapeutics' IND for GT-02287, advancing Parkinson's drug to Phase 2 trials in 3Q26
Gain Therapeutics received FDA clearance for its Investigational New Drug (IND) application for GT-02287, enabling the start of Phase 2 clinical trials for Parkinson’s disease in the U.S. during the third quarter of 2026. GT-02287 showed promising Ph...